Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing

Recruiting Observational Study
Amyotrophic Lateral Sclerosis Type 4 Inherited Neurological Disorders of RNA Processing
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
5 – 120
Sex
Any
Study type
Observational
Participants needed
330 (estimated)
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Amyotrophic lateral sclerosis type 4 (ALS4) is an inherited motor neuron disease. People with ALS4 have a change in the amount of RNA and DNA that bind together. This binding of RNA with DNA forms units called R-loops. Researchers want to learn how R-loops are related to ALS4. To do this, they will study people with inherited neurological conditions that may affect R-loop levels. Thes…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: ALS4 RNA metabolism inclusion criteria: * Age 5 or above * Genetic diagnosis of ALS4 (heterozygous mutation in SETX) * Able to communicate well with the investigator, to understand and comply with the requirements of the study * Capacity to consent (adults) or assent (pediatr…
Contacts

Angela D Kokkinis, R.N.

(301) 451-8146

akokkinis@mail.cc.nih.gov

CONTACT

Christopher Grunseich, M.D.

(301) 402-5423

grunseichc@mail.nih.gov

CONTACT